A summary of an ICER cost-effectiveness analysis published in JMCP found that despite incremental clinical benefits, biologics used to treat asthma have low long-term value for money.
This JMCP article assesses the ability of the BBCIC distributed research network to serve as a potential resource for surveillance of biologics. The study provides recommendations to improve future comparative safety and effectiveness studies of biologics.
This JMCP article showcases the impact of a pharmacist-to-pharmacist transition of care model in reducing acute care utilization rates for heart failure at 30 and 90 days.
The United States could face a health care crisis of an entirely different nature as a result of the COVID-19 pandemic. Health care professionals are warning about patients avoiding emergency rooms and office visits. Further, childhood vaccine rates are dropping to dangerous levels. Read about this perfect storm for health care in the latest AMCP CEO Blog.
AMCP Student Pharmacist Academy - Understanding the Fundamentals of Prescription Drug Pricing and the Supply Chain and Chapter Leadership Academy Turn-key Projects
The Academy of Managed Care Pharmacy (AMCP) thanks the Centers for Medicare & Medicaid Services (CMS) for the opportunity to provide comments in response to its Information Collection Request titled “Medication Therapy Management Improvements – Standardized Format (CMS-10396)” published on February 18, 2020.